Evaluation of Serum AMH to Assess Ovarian Reserve in Women with Severe Disease

Catalano, Angelica
March 2014
Fertility Weekly;3/10/2014, p8
Academic Journal
The article discusses the findings of a study conducted in Italy which examines the serum levels of anti-Mullerian hormone (AMH) in women with severe endometriosis to determine the effect of the disease on ovarian reserve. The study demonstrates the damage of ovarian reserve endometriosis, which is considered as an early sign of advanced ovarian depletion in young women. It suggests that AMH serum levels may be used in the follow-up of women with endometriosis to assess ovarian reserve..


Related Articles

  • Preoperative Serum Anti-Mullerian Hormone Level in Women with Ovarian Endometrioma and Mature Cystic Teratoma. Ju Yeong Kim; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim // Yonsei Medical Journal;Jul2013, Vol. 54 Issue 4, p921 

    Purpose: To investigate whether preoperative serum anti-mullerian hormone (AMH) levels are lower in women with ovarian endometrioma and in women with mature cystic teratoma of the ovaries. Materials and Methods: In a tertiary university hospital, a retrospective case-control study was performed....

  • AMH is a Useful Parameter for Classification.  // Fertility Weekly;8/6/2012, p1 

    The article reports on a study conducted by B. Wetzka and colleagues which examines the importance of anti-mullerian hormone (AMH) as primary variable for female androgenization (FA) classification. It says that the study classified 178 patients into five FA groups including ovary, adrenal...

  • Ovarian endometriomas and Anti-Mullerian hormone. Marshall, V.; Siebert, T. I. // Obstetrics & Gynaecology Forum;2014, Vol. 24 Issue 1, p21 

    Background: Endometriosis is common, affecting up to 10% of females in their reproductive years. The vast majority of sufferers present with pain and infertility. The etiology of endometriosis is thought to be due to retrograde menstruation and implantation of endometrial tissue onto visceral...

  • Nomogram to predict pregnancy rate after ICSI–IVF cycle in patients with endometriosis. Ballester, Marcos; Oppenheimer, Anne; Mathieu d'Argent, Emmanuelle; Touboul, Cyril; Antoine, Jean-Marie; Coutant, Charles; Daraï, Emile // Human Reproduction;Feb2012, Vol. 27 Issue 2, p451 

    BACKGROUND Although several scoring systems have been published to evaluate the pregnancy rate after ICSI–IVF in infertile patients, none of them are applicable for patients with deep infiltrating endometriosis (DIE) nor can they evaluate the chances of pregnancy for individual patients....

  • The physiology and clinical utility of anti-Müllerian hormone in women. Dewailly, Didier; Andersen, Claus Yding; Balen, Adam; Broekmans, Frank; Dilaver, Nafi; Fanchin, Renato; Griesinger, Georg; Kelsey, Tom W.; La Marca, Antonio; Lambalk, Cornelius; Mason, Helen; Nelson, Scott M.; Visser, Jenny A.; Wallace, W. Hamish; Anderson, Richard A. // Human Reproduction Update;May2014, Vol. 20 Issue 3, p370 

    BACKGROUND The measurement of circulating anti-Müllerian hormone (AMH) has been applied to a wide array of clinical applications, mainly based on its ability to reflect the number of antral and pre-antral follicles present in the ovaries. AMH has been suggested to predict the ovarian response...

  • The meaning of anti-Müllerian hormone levels in patients at a high risk of poor ovarian response. Hyun Jong Park; Geun Ho Lee; Du Sik Gong; Tae Ki Yoon; Woo Sik Lee // Clinical & Experimental Reproductive Medicine;Sep2016, Vol. 43 Issue 3, p139 

    Measurements of ovarian reserve play an important role in predicting the clinical results of assisted reproductive technology (ART). The ideal markers of ovarian reserve for clinical applications should have high specificity in order to determine genuine poor responders. Basal...

  • It’s Never over until It’s over: How Can Age and Ovarian Reserve Be Mathematically Bound through the Measurement of Serum AMH—A Study of 5069 Romanian Women. Doroftei, Bogdan; Mambet, Cristina; Zlei, Mihaela // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Wide regional differences in the age-related Anti Mullerian hormone (AMH) regression patterns or age at onset of natural menopause have been reported, possibly reflecting genetic, socioeconomic, environmental, racial or ethnic peculiarities. Moreover, adaptation of AMH levels from different...

  • Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. La Marca, Antonio; Sunkara, Sesh Kamal // Human Reproduction Update;Jan2014, Vol. 20 Issue 1, p124 

    BACKGROUND The main objective of individualization of treatment in IVF is to offer every single woman the best treatment tailored to her own unique characteristics, thus maximizing the chances of pregnancy and eliminating the iatrogenic and avoidable risks resulting from ovarian stimulation....

  • Evaluation of antimullerian hormone levels before and after laparoscopic management of endometriosis. Mostajeran, F.; Mannish, Z.; Rouholamin, S.; Zafarbakhsh, A. // Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p76 

    Introduction: Serum antimullerian hormone (AMH) proposed to be a reliable marker of ovarian reserve; the aim of this study was to evaluate the influence and value of laparoscopic management in endometriosis as measured by serum AMH levels. Materials and Methods: In this cross-sectional study, 33...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics